Postdischarge Anticoagulation Use Reduces VTE Risk After COVID-19 Hospitalization
Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge.
Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge.
These data suggest vaping poses potential threats to the development of the brain and organs, with teenagers being a predominant target due to surges in…
These survey results indicate that young adults tended to embrace misconceptions regarding sun protection and positive views of tanning.
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
These data suggest vaping poses potential threats to the development of the brain and organs, with teenagers being a predominant target due to surges in…
The April 2024 month in review features HCPLive’s top coverage of resmetirom, other key hepatic pipeline updates, and recent research about hepatitis C virus.
In this review of April 2024, the editorial team highlighted some of the biggest stories in the pulmonary health space, touching on topics such as…
An analysis of NHANES found aspirin’s benefits in primary prevention may hinge on lipoprotein(a) (Lp(a)) levels, halving ASCVD mortality risk with Lp(a) ≥50 mg/dL.
An analysis of NHANES found aspirin’s benefits in primary prevention may hinge on lipoprotein(a) (Lp(a)) levels, halving ASCVD mortality risk with Lp(a) ≥50 mg/dL.
The deep impact of mild plaque psoriasis
An analysis of NHANES found aspirin’s benefits in primary prevention may hinge on lipoprotein(a) (Lp(a)) levels, halving ASCVD mortality risk with Lp(a) ≥50 mg/dL.